AF
NUVB icon

Allworth Financial’s Nuvation Bio NUVB Stock Holding History

Allworth Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Buy
4,221
+1,127
+36% +$5.51K ﹤0.01% 3055
2026
Q1 		$13.3K Buy
3,094
+355
+13% +$1.98K ﹤0.01% 3300
2025
Q4 		$24.5K Sell
2,739
-52
-2% -$322 ﹤0.01% 2672
2025
Q3 		$10.3K Buy
2,791
+2,075
+290% +$5.65K ﹤0.01% 3122
2025
Q2 		$1.4K Buy
+716
New +$1.49K ﹤0.01% 3857
2022
Q4 		– Sell
-820
Closed -$2K – 3138
2022
Q3 		$2K Buy
+820
New +$2.34K ﹤0.01% 2190

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allworth Financial's NUVB Position: Q2 2026 in Review

Allworth Financial increased its Nuvation Bio (NUVB) stake by 36% in Q2 2026, buying an estimated $5.51K and bringing the position to 4,221 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Allworth Financial first reported a position in NUVB in Q3 2022 and has held it in 6 quarters since. The position peaked at $24.5K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Allworth Financial held 4,221 shares of Nuvation Bio worth $24K as of Q2 2026.
  • Allworth Financial bought 1,127 Nuvation Bio shares in Q2 2026, an estimated $5.51K.
  • Nuvation Bio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3055 holding.
  • Allworth Financial first reported a position in Nuvation Bio in Q3 2022 and has held it in 6 quarters since.
  • Allworth Financial's Nuvation Bio position peaked at $24.5K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.